Correction to “Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein” (Unbekannt)
- Neue Suche nach: Wang, Mingliang
- Neue Suche nach: Lu, Jianfeng
- Neue Suche nach: Wang, Mi
- Neue Suche nach: Yang, Chao-Yie
- Neue Suche nach: Wang, Shaomeng
- Weitere Informationen zu Wang, Shaomeng:
- https://orcid.org/0000-0002-8782-6950
- Neue Suche nach: Wang, Mingliang
- Neue Suche nach: Lu, Jianfeng
- Neue Suche nach: Wang, Mi
- Neue Suche nach: Yang, Chao-Yie
- Neue Suche nach: Wang, Shaomeng
- Weitere Informationen zu Wang, Shaomeng:
- https://orcid.org/0000-0002-8782-6950
In:
Journal of Medicinal Chemistry
;
64
, 1
;
906-908
;
2021
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Correction to “Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein”
-
Weitere Titelangaben:J. Med. Chem.
-
Beteiligte:Wang, Mingliang ( Autor:in ) / Lu, Jianfeng ( Autor:in ) / Wang, Mi ( Autor:in ) / Yang, Chao-Yie ( Autor:in ) / Wang, Shaomeng ( Autor:in )
-
Erschienen in:Journal of Medicinal Chemistry ; 64, 1 ; 906-908
-
Verlag:
- Neue Suche nach: American Chemical Society
-
Erscheinungsdatum:14.01.2021
-
ISSN:
-
Coden:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Unbekannt
-
Datenquelle:
Inhaltsverzeichnis – Band 64, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
2021: A New Year and New Directions for the Journal of Medicinal ChemistryLindsley, Craig W. et al. | 2021
- 2
-
Development and Therapeutic Potential of NUAKs InhibitorsFaisal, Muhammad / Kim, Jae Ho / Yoo, Kyung Ho / Roh, Eun Joo / Hong, Soon Sun / Lee, So Ha et al. | 2021
- 26
-
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?De Simone, Angela / Tumiatti, Vincenzo / Andrisano, Vincenza / Milelli, Andrea et al. | 2021
- 42
-
Recent Update on Targeting c‑MYC G‑Quadruplexes by Small Molecules for Anticancer TherapeuticsChaudhuri, Ritapa / Bhattacharya, Semantee / Dash, Jyotirmayee / Bhattacharya, Santanu et al. | 2021
- 71
-
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against TuberculosisShyam, Mousumi / Shilkar, Deepak / Verma, Harshita / Dev, Abhimanyu / Sinha, Barij Nayan / Brucoli, Federico / Bhakta, Sanjib / Jayaprakash, Venkatesan et al. | 2021
- 101
-
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical SpaceSchwaid, Adam G. / Spencer, Kerrie B. et al. | 2021
- 123
-
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer DevelopmentHou, Lu / Rong, Jian / Haider, Ahmed / Ogasawara, Daisuke / Varlow, Cassis / Schafroth, Michael A. / Mu, Linjing / Gan, Jiefeng / Xu, Hao / Fowler, Christopher J. et al. | 2021
- 150
-
Spirocyclic Scaffolds in Medicinal ChemistryHiesinger, Kerstin / Dar’in, Dmitry / Proschak, Ewgenij / Krasavin, Mikhail et al. | 2021
- 184
-
Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural ProductsSun, Cheng-Peng / Zhang, Xin-Yue / Morisseau, Christophe / Hwang, Sung Hee / Zhang, Zhan-Jun / Hammock, Bruce D. / Ma, Xiao-Chi et al. | 2021
- 216
-
Peptide–Drug Conjugates with Different Linkers for Cancer TherapyAlas, Mona / Saghaeidehkordi, Azam / Kaur, Kamaljit et al. | 2021
- 233
-
TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future ProspectsKaur, Arshpreet / Kaushik, Deepender / Piplani, Sakshi / Mehta, Surinder K. / Petrovsky, Nikolai / Salunke, Deepak B. et al. | 2021
- 279
-
Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid NetworkSkácel, Jan / Slusher, Barbara S. / Tsukamoto, Takashi et al. | 2021
- 298
-
Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related DiseasesWang, Pengfei / Gong, Qijie / Hu, Jiabao / Li, Xiang / Zhang, Xiaojin et al. | 2021
- 326
-
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell DiseaseGopalsamy, Ariamala / Aulabaugh, Ann E. / Barakat, Amey / Beaumont, Kevin C. / Cabral, Shawn / Canterbury, Daniel P. / Casimiro-Garcia, Agustin / Chang, Jeanne S. / Chen, Ming Z. / Choi, Chulho et al. | 2021
- 343
-
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic FibrosisVan der Plas, Steven E. / Kelgtermans, Hans / Mammoliti, Oscar / Menet, Christel / Tricarico, Giovanni / De Blieck, Ann / Joannesse, Caroline / De Munck, Tom / Lambin, Dominique / Cowart, Marlon et al. | 2021
- 354
-
When Macrocyclic Peptides Meet the Crystal Structure of a Melanocortin ReceptorGrieco, Paolo et al. | 2021
- 357
-
Structure-Based Design of Melanocortin 4 Receptor Ligands Based on the SHU-9119-hMC4R Cocrystal StructureMartin, Charlotte / Gimenez, Luis E. / Williams, Savannah Y. / Jing, Yu / Wu, Yiran / Hollanders, Charlie / Van der Poorten, Olivier / Gonzalez, Simon / Van holsbeeck, Kevin / Previti, Santo et al. | 2021
- 370
-
Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity ShiftThorat, Shivaji A. / Lee, Yoonji / Jung, Aeran / Ann, Jihyae / Ahn, Songyeon / Baek, Jisoo / Zuo, Dongxu / Do, Nayeon / Jeong, Jin Ju / Blumberg, Peter M. et al. | 2021
- 385
-
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic SclerosisJiang, Bei-Er / Jiang, Xingwu / Zhang, Qiansen / Liang, Qiuwen / Qiu, Zi-Liang / Sun, Xiang-Bai / Yang, Jun-Jie / Chen, Si / Yi, Chunyang / Chai, Xiaolei et al. | 2021
- 404
-
Covalent Inhibition of Bacterial Urease by Bifunctional Catechol-Based Phosphonates and PhosphinatesPagoni, Aikaterini / Grabowiecka, Agnieszka / Tabor, Wojciech / Mucha, Artur / Vassiliou, Stamatia / Berlicki, Łukasz et al. | 2021
- 417
-
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug DesignDietrich, Justin D. / Longenecker, Kenton L. / Wilson, Noel S. / Goess, Christian / Panchal, Sanjay C. / Swann, Steven L. / Petros, Andrew M. / Hobson, Adrian D. / Ihle, David / Song, Danying et al. | 2021
- 430
-
Discovery of a “Gatekeeper” Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR HeterodimersWatanabe, Masaki / Fujihara, Michiko / Motoyama, Tomoharu / Kawasaki, Mayu / Yamada, Shoya / Takamura, Yuta / Ito, Sohei / Makishima, Makoto / Nakano, Shogo / Kakuta, Hiroki et al. | 2021
- 440
-
2‑((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F420)‑Dependent Nitroreductase (Ddn)Jian, Yanlin / Forbes, He Eun / Hulpia, Fabian / Risseeuw, Martijn D. P. / Caljon, Guy / Munier-Lehmann, Hélène / Boshoff, Helena I. M. / Van Calenbergh, Serge et al. | 2021
- 458
-
3,4-Dihydropyrimidin-2(1H)‑ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific RecognitionMajellaro, María / Jespers, Willem / Crespo, Abel / Núñez, María J. / Novio, Silvia / Azuaje, Jhonny / Prieto-Díaz, Rubén / Gioé, Claudia / Alispahic, Belma / Brea, José et al. | 2021
- 481
-
Structure–Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N‑Acylphosphatidylethanolamine Phospholipase DMock, Elliot D. / Kotsogianni, Ioli / Driever, Wouter P. F. / Fonseca, Carmen S. / Vooijs, Jelle M. / den Dulk, Hans / van Boeckel, Constant A. A. / van der Stelt, Mario et al. | 2021
- 516
-
Lithocholic Acid Derivatives as Potent Vitamin D Receptor AgonistsSasaki, Harue / Masuno, Hiroyuki / Kawasaki, Haru / Yoshihara, Ayana / Numoto, Nobutaka / Ito, Nobutoshi / Ishida, Hiroaki / Yamamoto, Keiko / Hirata, Naoya / Kanda, Yasunari et al. | 2021
- 527
-
Sialyltransferase Inhibitors Suppress Breast Cancer MetastasisFu, Chih-Wei / Tsai, Han-En / Chen, Wei-Sheng / Chang, Tzu-Ting / Chen, Chia-Ling / Hsiao, Pei-Wen / Li, Wen-Shan et al. | 2021
- 543
-
Potent and Specific Inhibition of NTCP-Mediated HBV/HDV Infection and Substrate Transporting by a Novel, Oral-Available Cyclosporine A AnalogueLiu, Yang / Ruan, Hanying / Li, Ying / Sun, Guoliang / Liu, Xiao / He, Wenhui / Mao, Fengfeng / He, Miaomiao / Yan, Liwei / Zhong, Guocai et al. | 2021
- 566
-
Generation of Highly Selective, Potent, and Covalent G Protein-Coupled Receptor Kinase 5 InhibitorsRowlands, Rachel A. / Chen, Qiuyan / Bouley, Renee A. / Avramova, Larisa V. / Tesmer, John J. G. / White, Andrew D. et al. | 2021
- 586
-
Tuning the Biological Activity of RGD Peptides with HalotryptophansKemker, Isabell / Schröder, David C. / Feiner, Rebecca C. / Müller, Kristian M. / Marion, Antoine / Sewald, Norbert et al. | 2021
- 602
-
Structure–Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin ReceptorTrân, Kien / Murza, Alexandre / Sainsily, Xavier / Delile, Eugénie / Couvineau, Pierre / Côté, Jérôme / Coquerel, David / Peloquin, Maude / Auger-Messier, Mannix / Bouvier, Michel et al. | 2021
- 616
-
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320Kjeldsen, Thomas B. / Hubálek, František / Tagmose, Tina M. / Pridal, Lone / Refsgaard, Hanne H. F. / Porsgaard, Trine / Gram-Nielsen, Sanne / Hovgaard, Lars / Valore, Henrik / Münzel, Martin et al. | 2021
- 629
-
Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor MicroenvironmentKang, Zisheng / Wang, Cong / Tong, Yu / Li, Yanyi / Gao, Yi / Hou, Siyuan / Hao, Meixi / Han, Xiaolin / Wang, Bin / Wang, Qianqian et al. | 2021
- 644
-
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)Cheng, Hengmiao / Orr, Suvi T. M. / Bailey, Simon / Brooun, Alexei / Chen, Ping / Deal, Judith G. / Deng, Yali L. / Edwards, Martin P. / Gallego, Gary M. / Grodsky, Neil et al. | 2021
- 662
-
A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative PhosphorylationKulkarni, Chaitanya A. / Fink, Brian D. / Gibbs, Bettine E. / Chheda, Pratik R. / Wu, Meng / Sivitz, William I. / Kerns, Robert J. et al. | 2021
- 677
-
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2Liu, Chunjian / Lin, James / Langevine, Charles / Smith, Daniel / Li, Jianqing / Tokarski, John S. / Khan, Javed / Ruzanov, Max / Strnad, Joann / Zupa-Fernandez, Adriana et al. | 2021
- 695
-
Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 InhibitorsBrotherton-Pleiss, Christine / Yue, Peibin / Zhu, Yinsong / Nakamura, Kayo / Chen, Weiliang / Fu, Wenzhen / Kubota, Casie / Chen, Jasmine / Alonso-Valenteen, Felix / Mikhael, Simoun et al. | 2021
- 711
-
Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8‑trifluoromethyl-2′-deoxyguanosineBao, Hong-Liang / Ishizuka, Takumi / Yamashita, Atsushi / Furukoji, Eiji / Asada, Yujiro / Xu, Yan et al. | 2021
- 719
-
Antitubercular 2‑Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action StudiesSoares de Melo, Candice / Singh, Vinayak / Myrick, Alissa / Simelane, Sandile B. / Taylor, Dale / Brunschwig, Christel / Lawrence, Nina / Schnappinger, Dirk / Engelhart, Curtis A. / Kumar, Anuradha et al. | 2021
- 741
-
Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of CancerCheruku, Ravindra R. / Cacaccio, Joseph / Durrani, Farukh A. / Tabaczynski, Walter A. / Watson, Ramona / Siters, Kevin / Missert, Joseph R. / Tracy, Erin C. / Dukh, Mykhaylo / Guru, Khurshid et al. | 2021
- 768
-
Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory ActivityZeng, Qingxuan / Deng, Hongbin / Li, Yinghong / Fan, Tianyun / Liu, Yang / Tang, Sheng / Wei, Wei / Liu, Xiaojia / Guo, Xixi / Jiang, Jiandong et al. | 2021
- 782
-
Tenofovir-Amino Acid Conjugates Act as Polymerase SubstratesImplications for Avoiding Cellular Phosphorylation in the Discovery of Nucleotide AnaloguesGu, Weijie / Martinez, Sergio / Nguyen, Hoai / Xu, Hongtao / Herdewijn, Piet / De Jonghe, Steven / Das, Kalyan et al. | 2021
- 797
-
Diflunisal Derivatives as Modulators of ACMS Decarboxylase Targeting the Tryptophan–Kynurenine PathwayYang, Yu / Borel, Timothy / de Azambuja, Francisco / Johnson, David / Sorrentino, Jacob P. / Udokwu, Chinedum / Davis, Ian / Liu, Aimin / Altman, Ryan A. et al. | 2021
- 812
-
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 MiceViayna, Elisabet / Coquelle, Nicolas / Cieslikiewicz-Bouet, Monika / Cisternas, Pedro / Oliva, Carolina A. / Sánchez-López, Elena / Ettcheto, Miren / Bartolini, Manuela / De Simone, Angela / Ricchini, Mattia et al. | 2021
- 840
-
1‑Methyl‑1H‑pyrazole-5-carboxamide Derivatives Exhibit Unexpected Acute Mammalian ToxicityPreston, Sarah / Garcia-Bustos, Jose / Hall, Liam G. / Martin, Sheree D. / Le, Thuy G. / Kundu, Abhijit / Ghoshal, Atanu / Nguyen, Nghi H. / Jiao, Yaqing / Ruan, Banfeng et al. | 2021
- 845
-
Discovery of Potent and Selective Methylenephosphonic Acid CD73 InhibitorsSharif, Ehesan U. / Kalisiak, Jaroslaw / Lawson, Kenneth V. / Miles, Dillon H. / Newcomb, Eric / Lindsey, Erick A. / Rosen, Brandon R. / Debien, Laurent P. P. / Chen, Ada / Zhao, Xiaoning et al. | 2021
- 861
-
Convenient Retinoid X Receptor Binding Assay Based on Fluorescence Change of the Antagonist NEt-C343Yukawa-Takamatsu, Kayo / Wang, Yifei / Watanabe, Masaki / Takamura, Yuta / Fujihara, Michiko / Nakamura-Nakayama, Mariko / Yamada, Shoya / Kikuzawa, Shota / Makishima, Makoto / Kawasaki, Mayu et al. | 2021
- 871
-
Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse ColitisDai, Zhen / Chen, Xiao-yi / An, Lu-yan / Li, Cui-cui / Zhao, Ni / Yang, Fan / You, Song-tao / Hou, Chen-zhi / Li, Kan / Jiang, Cheng et al. | 2021
- 890
-
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain ManagementPeng, Youyi / Zhang, Qiang / Welsh, William J. et al. | 2021
- 905
-
Correction to Structure–Activity Relationship of SPOP Inhibitors against Kidney CancerDong, Ze / Wang, Zhen / Guo, Zhong-Qiang / Gong, Shouzhe / Zhang, Tao / Liu, Jiang / Luo, Cheng / Jiang, Hualiang / Yang, Cai-Guang et al. | 2021
- 906
-
Correction to “Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein”Wang, Mingliang / Lu, Jianfeng / Wang, Mi / Yang, Chao-Yie / Wang, Shaomeng et al. | 2021